Arcutis Biotherapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Arcutis Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Arcutis Biotherapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Arcutis Biotherapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $2.4M | 733k | 3.23 |
| 2023-09-30 | $1.8M | 333k | 5.31 |
| 2023-06-30 | $6.6M | 694k | 9.53 |
| 2023-03-31 | $2.7M | 247k | 11.00 |
| 2022-12-31 | $4.1M | 280k | 14.80 |
| 2022-06-30 | $2.0M | 96k | 21.31 |
| 2022-03-31 | $1.2M | 63k | 19.25 |
| 2021-12-31 | $1000k | 48k | 20.73 |
| 2021-09-30 | $971k | 41k | 23.91 |
| 2021-03-31 | $619k | 21k | 28.93 |
| 2020-12-31 | $6.3M | 225k | 28.12 |
| 2020-09-30 | $5.3M | 179k | 29.35 |
| 2020-06-30 | $5.2M | 172k | 30.24 |